179 related articles for article (PubMed ID: 28769759)
21. Protective action of erythropoietin on neuronal damage induced by activated microglia.
Wenker SD; Chamorro ME; Vittori DC; Nesse AB
FEBS J; 2013 Apr; 280(7):1630-42. PubMed ID: 23384249
[TBL] [Abstract][Full Text] [Related]
22. Neuroprotective effects of erythropoietin posttreatment against kainate-induced excitotoxicity in mixed spinal cultures.
Yoo JY; Won YJ; Lee JH; Kim JU; Sung IY; Hwang SJ; Kim MJ; Hong HN
J Neurosci Res; 2009 Jan; 87(1):150-63. PubMed ID: 18711747
[TBL] [Abstract][Full Text] [Related]
23. Erythropoietin and carbamylated erythropoietin are neuroprotective following spinal cord hemisection in the rat.
King VR; Averill SA; Hewazy D; Priestley JV; Torup L; Michael-Titus AT
Eur J Neurosci; 2007 Jul; 26(1):90-100. PubMed ID: 17614942
[TBL] [Abstract][Full Text] [Related]
24. [Erythropoietin--a new therapy in cerebral ischemia?].
Kalialis LV; Olsen NV
Ugeskr Laeger; 2003 Jun; 165(24):2477-81. PubMed ID: 12872467
[TBL] [Abstract][Full Text] [Related]
25. Intrinsic and extrinsic erythropoietin enhances neuroprotection against ischemia and reperfusion injury in vitro.
Liu R; Suzuki A; Guo Z; Mizuno Y; Urabe T
J Neurochem; 2006 Feb; 96(4):1101-10. PubMed ID: 16417583
[TBL] [Abstract][Full Text] [Related]
26. Neuroprotective effect of erythropoietin in amyotrophic lateral sclerosis (ALS) model in vitro. Ultrastructural study.
Nagańska E; Taraszewska A; Matyja E; Grieb P; Rafałowska J
Folia Neuropathol; 2010; 48(1):35-44. PubMed ID: 20383809
[TBL] [Abstract][Full Text] [Related]
27. Erythropoietin 2nd cerebral protection after acute injuries: a double-edged sword?
Velly L; Pellegrini L; Guillet B; Bruder N; Pisano P
Pharmacol Ther; 2010 Dec; 128(3):445-59. PubMed ID: 20732352
[TBL] [Abstract][Full Text] [Related]
28. A "classical" homodimeric erythropoietin receptor is essential for the antiapoptotic effects of erythropoietin on differentiated neuroblastoma SH-SY5Y and pheochromocytoma PC-12 cells.
Um M; Gross AW; Lodish HF
Cell Signal; 2007 Mar; 19(3):634-45. PubMed ID: 17045782
[TBL] [Abstract][Full Text] [Related]
29. Delayed administration of erythropoietin and its non-erythropoietic derivatives ameliorates chronic murine autoimmune encephalomyelitis.
Savino C; Pedotti R; Baggi F; Ubiali F; Gallo B; Nava S; Bigini P; Barbera S; Fumagalli E; Mennini T; Vezzani A; Rizzi M; Coleman T; Cerami A; Brines M; Ghezzi P; Bianchi R
J Neuroimmunol; 2006 Mar; 172(1-2):27-37. PubMed ID: 16337691
[TBL] [Abstract][Full Text] [Related]
30. Experimental evidence of the potential use of erythropoietin by intranasal administration as a neuroprotective agent in cerebral hypoxia.
Merelli A; Caltana L; Lazarowski A; Brusco A
Drug Metabol Drug Interact; 2011; 26(2):65-9. PubMed ID: 21756166
[TBL] [Abstract][Full Text] [Related]
31. Erythropoietin and normal brain development: receptor expression determines multi-tissue response.
Chen ZY; Warin R; Noguchi CT
Neurodegener Dis; 2006; 3(1-2):68-75. PubMed ID: 16909040
[TBL] [Abstract][Full Text] [Related]
32. Erythropoietin in the central nervous system, and its use to prevent hypoxic-ischemic brain damage.
Juul S
Acta Paediatr Suppl; 2002; 91(438):36-42. PubMed ID: 12477263
[TBL] [Abstract][Full Text] [Related]
33. Neuroprotection by hypoxic preconditioning involves oxidative stress-mediated expression of hypoxia-inducible factor and erythropoietin.
Liu J; Narasimhan P; Yu F; Chan PH
Stroke; 2005 Jun; 36(6):1264-9. PubMed ID: 15890996
[TBL] [Abstract][Full Text] [Related]
34. In vivo evidence that erythropoietin protects neurons from ischemic damage.
Sakanaka M; Wen TC; Matsuda S; Masuda S; Morishita E; Nagao M; Sasaki R
Proc Natl Acad Sci U S A; 1998 Apr; 95(8):4635-40. PubMed ID: 9539790
[TBL] [Abstract][Full Text] [Related]
35. [Hematopoietic growth factor EPO has neuro-protective and neuro-trophic effects--review].
Zhou ZY; Yang M; Fok TF
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Apr; 13(2):332-7. PubMed ID: 15854305
[TBL] [Abstract][Full Text] [Related]
36. Brain-derived erythropoietin protects from focal cerebral ischemia by dual activation of ERK-1/-2 and Akt pathways.
Kilic E; Kilic U; Soliz J; Bassetti CL; Gassmann M; Hermann DM
FASEB J; 2005 Dec; 19(14):2026-8. PubMed ID: 16207820
[TBL] [Abstract][Full Text] [Related]
37. Neuroprotective effect of erythropoietin on hypoxic-ischemic brain injury in neonatal rats.
Kumral A; Ozer E; Yilmaz O; Akhisaroglu M; Gokmen N; Duman N; Ulukus C; Genc S; Ozkan H
Biol Neonate; 2003; 83(3):224-8. PubMed ID: 12660442
[TBL] [Abstract][Full Text] [Related]
38. Physician Education: The Erythropoietin Receptor and Signal Transduction.
Yoshimura A; Arai K
Oncologist; 1996; 1(5):337-339. PubMed ID: 10388012
[TBL] [Abstract][Full Text] [Related]
39. Comparison of neuroprotective effects of erythropoietin (EPO) and carbamylerythropoietin (CEPO) against ischemia-like oxygen-glucose deprivation (OGD) and NMDA excitotoxicity in mouse hippocampal slice cultures.
Montero M; Poulsen FR; Noraberg J; Kirkeby A; van Beek J; Leist M; Zimmer J
Exp Neurol; 2007 Mar; 204(1):106-17. PubMed ID: 17157835
[TBL] [Abstract][Full Text] [Related]
40. Up-regulation of erythropoietin receptor by nitric oxide mediates hypoxia preconditioning.
Chen ZY; Wang L; Asavaritkrai P; Noguchi CT
J Neurosci Res; 2010 Nov; 88(14):3180-8. PubMed ID: 20806411
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
